Cost Analysis of Haemodialysis Patients in Government Tertiary Care Centre – A Pharmacoeconomic Study
Abstract
The progression of chronic kidney disease (CKD) to End-Stage Renal Disease (ESRD) in India is rapidly increasing. Over 25 million of people suffering from ESRD, especially in rural areas. Many of these patients are not undergoing dialysis due to the factors such as lack of awareness, fewer treatment options, unaffordability prices due to low income, and minor reimbursement for chronic illness. The cost of hemodialysis in private hospitals is around 12.000 INR (Indian Rupee) per person monthly and 140.000 INR per year, which seem too expensive for middle and lower-middle-class of patients. Hence our study was aimed to analyze the healthcare cost of hemodialysis in government tertiary health care centers by analyzing the direct and indirect cost from the patient perspective. Sixty patients who underwent dialysis in Hassan Institute of Medical Sciences Teaching Hospital were included in this study. The demographic details, past and present medical history, cost per session of dialysis, laboratory examination, money spent on travel, and the working days lost were calculated. Out of 60 patient (male: 47; female: 17), 53 patients aged 18-65 years old. They belonged to lower-middle (38.33%), middle (23.33%), lower (21.66%), and upper-middle-class (8%). The average direct medical cost of each patient in one session of dialysis was 481.5 INR and indirect medical costs were 557.33 INR. Based on our observation, we conclude that the patients are having satisfactory outcomes, comparatively at low cost in our government dialysis unit. Government should encourage and also cover the mobile dialysis centers under government health schemes, by which the indirect medical cost can be reduced.
Keywords
Full Text:
PDFReferences
Pashos CL, Klein EG, Wanke LA. ISPOR Lexicon. 1st ed. Princeton, N. International Society for Pharmacoeconomics and Outcome Research. 1998.
Ahmad, A., Patel, I., Parimilakrishnan, S., Mohanta, G. P., Chung, H., & Chang, J. (2013). The role of pharmacoeconomics in current Indian healthcare system. Journal of research in pharmacy practice.2013.2(1):3–9.
Bhowmik, Debjit, S. Duraivel, A. N. Rajalakshmi, and S. Kumar. Pharmacoeconomics-A Review. Pharmacy.2014.6(9): 672-675
Juan GP, Luke V, Sally CS, Sarah W. Haemodialysis for ESRD: A costeffectiveness analysis of treatment options. International Journal of technology assessment in Healthcare
;21:32-9.
Rajapurkar M, Dabhi M. Burden of disease—prevalence and incidence of renal disease in India. Clinical Nephrology. 2010 Nov 1;74(1):S9.
Ballal HS. The burden of chronic kidney disease in a developing country, India. Ouest. 2007;9:12–9.
Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrology Dialysis Transplantation. 2005; 20:1638–42.
Mani MK. Prevention of chronic renal failure at the community level. Kidney International. 2003;(83):S86–9.
Crealey GE, Sturgess IK, McElnay JC, Hughes CM. Pharmaceutical care programmes for the Elderly:
Economic issues. Pharmaeconomics. 2003;21:455–65.
Khanna U. The economics of dialysis in India. Indian journal of Nephrology. 2009;19:1–4.
Dirks J, Zeeuw D, Agarwal S, Atkins R, Rotter R, Amico G, et al. Prevention of the chronic kidney and vascular disease: Towards global health equity–the Bellagio 2004 Declaration. Kidney International. 2005;98:s1–s6.
Suja A, Anju R, Anju V, Neethu J, Peeyush P, Saraswathy R. Economic evaluation of end stage renal disease
patients undergoing haemodialysis. Journal of Pharmacy and Bioapllied Sciences. 2012 Apr;4(2):107.
Fathima S, Mateti UV, Philip ML, Kamath J. Pharmacoeconomic evaluation of haemodialysis patients: A study of cost of illness. Journal of Integrative Nephrology and Andrology. 2018 Apr 1;5(2):54.
Sharma, Rahul. Revision of Prasad’s social classification and provision of an online tool for real-time updating.
South Asian Journal of Cancer. 2013;2(3):157.
Anita N, Fathima TT, Mrudula G. Pharmacoeconomic evaluation in end stage renal disease patients. Journal of Pharmaceutical Research. 2016 Jan-Mar;16(1):14-18
Kher V. End stage renal disease in developing countries. Kidney International. 2002; 62:350-62.
Khanna U. The economics of dialysis in India. Indian Journal of Nephrology 2009;19:1-4.
Phuong JM, Penm J, Chaar B, Oldfield LD, Moles R. The impacts of medication shortages on patient outcomes: A scoping review. PLoS One. 2019;14(5):e0215837. P
Sandeep kudtarkar. Dialysis healthcare delivery in India.
Conference paper: Sies Health Care Conference. 2014
Setting up of hemodialysis unit. Indian Journal of Nephrology. 2020. 4(30):1-5
DOI: https://doi.org/10.15416/pcpr.v6i2.32069
Refbacks
- There are currently no refbacks.